Clinical Trial

Influence of Preoperative Immunomodulation by Oral Impact on Postoperative Complications Following Cystectomies & Nephrectomies

Study acronym: IMPACTURO
Unknown
View on ClinicalTrials.gov →
Record status
This record was last updated July 15, 2024 (before its estimated January 2025 completion). Its status may not reflect the trial's current state.
Summary
any studies have shown the benefit of perioperative Oral Impact immunomodulation in gastrointestinal, ENT, gynecological and cardiac surgery. Studies in major Urological surgery are rare and not very contributory. The expected benefit is a reduction in postoperative complications and the average length of stay.
Protocol Amendment History 1 change
critical Trial status changed: Recruiting → Unknown 2026-08-02
Trial Details
NCT Number NCT05520151
Lead Sponsor Centre Hospitalier Intercommunal Robert Ballanger
Conditions Urological Manifestations
Enrollment 214 participants
Start Date 2022-11-30
Primary Completion 2025-01 (estimated)
Study Completion 2025-06 (estimated)
Updated on ClinicalTrials.gov 2024-07-15